company background image
CRM logo

PZ Cormay WSE:CRM Stock Report

Last Price

zł0.44

Market Cap

zł37.1m

7D

1.9%

1Y

-34.3%

Updated

06 Feb, 2025

Data

Company Financials

CRM Stock Overview

Develops, manufactures, and sells diagnostic reagents in Poland. More details

CRM fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

PZ Cormay S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for PZ Cormay
Historical stock prices
Current Share Pricezł0.44
52 Week Highzł0.68
52 Week Lowzł0.35
Beta0.73
1 Month Change5.26%
3 Month Change-8.33%
1 Year Change-34.33%
3 Year Change-61.84%
5 Year Change-53.83%
Change since IPO-74.12%

Recent News & Updates

Recent updates

Fewer Investors Than Expected Jumping On PZ Cormay S.A. (WSE:CRM)

Sep 08
Fewer Investors Than Expected Jumping On PZ Cormay S.A. (WSE:CRM)

There's Been No Shortage Of Growth Recently For PZ Cormay's (WSE:CRM) Returns On Capital

Feb 27
There's Been No Shortage Of Growth Recently For PZ Cormay's (WSE:CRM) Returns On Capital

PZ Cormay (WSE:CRM) Is Experiencing Growth In Returns On Capital

Sep 15
PZ Cormay (WSE:CRM) Is Experiencing Growth In Returns On Capital

Shareholder Returns

CRMPL Medical EquipmentPL Market
7D1.9%0.3%0.7%
1Y-34.3%-19.2%5.1%

Return vs Industry: CRM underperformed the Polish Medical Equipment industry which returned -20.6% over the past year.

Return vs Market: CRM underperformed the Polish Market which returned 1.3% over the past year.

Price Volatility

Is CRM's price volatile compared to industry and market?
CRM volatility
CRM Average Weekly Movement9.1%
Medical Equipment Industry Average Movement6.9%
Market Average Movement5.4%
10% most volatile stocks in PL Market10.0%
10% least volatile stocks in PL Market3.5%

Stable Share Price: CRM's share price has been volatile over the past 3 months compared to the Polish market.

Volatility Over Time: CRM's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Polish stocks.

About the Company

FoundedEmployeesCEOWebsite
1985n/aFlavio Finotellocormay.com

PZ Cormay S.A. develops, manufactures, and sells diagnostic reagents in Poland. It offers testing products for clinical chemistry, electrophoresis, hematology, veterinary, coagulology, blood group serology, immunology, immunochemistry, molecular biology, sampling, oncological surgery, and general analytics, as well as vacuum blood collection system. The company offers its products under the Orphée and Diesse brand names.

PZ Cormay S.A. Fundamentals Summary

How do PZ Cormay's earnings and revenue compare to its market cap?
CRM fundamental statistics
Market capzł37.05m
Earnings (TTM)-zł4.70m
Revenue (TTM)zł84.06m

0.4x

P/S Ratio

-7.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CRM income statement (TTM)
Revenuezł84.06m
Cost of Revenuezł50.34m
Gross Profitzł33.72m
Other Expenseszł38.42m
Earnings-zł4.70m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.056
Gross Margin40.11%
Net Profit Margin-5.60%
Debt/Equity Ratio0%

How did CRM perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 04:47
End of Day Share Price 2025/02/06 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PZ Cormay S.A. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pawel PuchalskiSantander Brokerage Poland
Lukasz KosiarskiSantander Brokerage Poland